Why the study?
Data related to potentially life-threatening cardiotoxicity, especially bradyarrhythmias, from 5-fluorouracil are lacking in the literature.
Does continuous 5-fluorouracil (5-FU) infusion cause potentially life-threatening bradyarrhythmias in patients with esophageal carcinomas?
Does continuous 5-fluorouracil (5-FU) infusion cause potentially life-threatening bradyarrhythmias in patients with esophageal carcinomas?
Answers are grounded in this paper and cite their sources.
Continuous 5-fluorouracil infusion is associated with a significant risk of severe bradycardia, necessitating vigilant electrocardiographic monitoring and potential switch to alternative therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wani et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: